QSAM Biosciences Book/Share
What is the Book/Share of QSAM Biosciences?
The Book/Share of QSAM Biosciences, Inc. is -0.01
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on OTC compared to QSAM Biosciences
What does QSAM Biosciences do?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Companies with book/share similar to QSAM Biosciences
- Backstageplay has Book/Share of -0.01
- Resources of Australia Ltd has Book/Share of -0.01
- Dragontail Systems has Book/Share of -0.01
- Paleo Resources has Book/Share of -0.01
- Ezagoo has Book/Share of -0.01
- Monarca Minerals has Book/Share of -0.01
- QSAM Biosciences has Book/Share of -0.01
- Newtopia has Book/Share of -0.01
- Oceanic Wind has Book/Share of -0.01
- 22nd Century Inc has Book/Share of -0.01
- Blockchain Industries has Book/Share of -0.01
- Pareteum Corp has Book/Share of -0.01
- Pareteum Corp has Book/Share of -0.01